2019
DOI: 10.4103/joacp.joacp_70_18
|View full text |Cite
|
Sign up to set email alerts
|

The estimation of minimum effective volume of 0.5% ropivacaine in ultrasound-guided interscalene brachial plexus nerve block: A clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…In general, lower volume and concentration of the LA are less likely to produce clinical symptoms of phrenic nerve paralysis but are additionally less likely to produce a dense enough block to provide adequate analgesia. Starting with volume, a prior study noted a minimum effective volume for 90% of patients as 8.64 mL of 0.5% ropivacaine [ 12 ]. Other previous studies have mentioned utilizing 5 mL of ropivacaine 0.5% or 0.75% as an effective dose for ISB with less likelihood of respiratory complications [ 8 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In general, lower volume and concentration of the LA are less likely to produce clinical symptoms of phrenic nerve paralysis but are additionally less likely to produce a dense enough block to provide adequate analgesia. Starting with volume, a prior study noted a minimum effective volume for 90% of patients as 8.64 mL of 0.5% ropivacaine [ 12 ]. Other previous studies have mentioned utilizing 5 mL of ropivacaine 0.5% or 0.75% as an effective dose for ISB with less likelihood of respiratory complications [ 8 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…This is due to compensation from the contralateral diaphragm and is most likely to occur in patients with adequate pulmonary reserve [9]. This nerve block is relatively contraindicated in patients with significant underlying pulmonary disease, especially chronic obstructive pulmonary disease (COPD), as the ISB has been shown to frequently result in a significant reduction in forced expiratory volume at one second (FEV1) [10][11][12][13]. In addition to COPD patients, the block is absolutely contraindicated in patients with a history of contralateral phrenic nerve damage.…”
Section: Introductionmentioning
confidence: 99%
“…This BCD approach avoids the drawback of estimating ED 95 using unproven ED 50 ( Pace and Stylianou, 2007 ; Tang et al, 2020 ; Zhu et al, 2020 ; Ni et al, 2022 ) because the peak dose distribution of ED 50 is similar to the average. Therefore, the BCD method combined with the estimation of isotonic regression is often used in anesthesia studies ( Mittal et al, 2019 ; Kewlani et al, 2021 ; Wu et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Mittal et al [8] determined that the minimum effective volume of 0.5% ropivacaine was 8.64 mL in 90% of patients who underwent ISB without deterioration in the block onset and duration. A similar study by Vandepitte et al [9] found that effective dose 95% (ED95) of 0.75% ropivacaine was 7 mL for successful surgical anesthesia with ISB using a catheter.…”
Section: Discussionmentioning
confidence: 99%